DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Durect (DRRX – Research Report) today. The company’s shares opened today at ...

H.C. Wainwright analyst Ed Arce keeps a Neutral rating on Durect (DRRX) without a price target after the company announced that data from the ...

The Health Foundation of South Florida, the region's largest philanthropic organization dedicated to improving community ...

ReviveMed, an MIT spinout at the forefront of artificial intelligence and precision medicine, today announced the release of a new preprint on bioRxiv describing mzLearn, a novel, data-driven ...

At the close in NYSE, the Dow... DURECT (DRRX +10.8%) jumps on triple normal volume in conjunction with the rally in Pain Therapeutics (PTIE +144.5%) after the latter reported positive results ...

Research reports are not currently available for DRRX.

After hours: January 24 at 7:23:36 PM EST ...

Merck & Co. Inc. 0.85% $248.61B ...

After hours: January 29 at 6:46:05 p.m. EST Loading Chart for RMTI ...

At close: 27 January at 3:00:00 pm GMT-5 ...